Viewing StudyNCT06371482



Ignite Creation Date: 2024-05-06 @ 8:24 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06371482
Status: RECRUITING
Last Update Posted: 2024-06-17
First Post: 2024-03-27

Brief Title: Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer Camel-01
Sponsor: Hebei Medical University Fourth Hospital
Organization: Hebei Medical University Fourth Hospital

Conditions & Keywords Data

Conditions:
Name
SCLC Limited Stage
Keywords:
Name View
Durvalumab View
SCLC Limited Stage View
immunotherapy View
chemoradiotherapy View